Exicure (XCUR) Cash from Investing Activities (QoQ) (2017 - 2025)
Exicure (XCUR) Cash from Investing Activities (QoQ) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Exicure |
17.53 Mn |
14.92 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
321.30% |
| Sep 30, 2025 |
138.57% |
| Jun 30, 2025 |
86.60% |
| Jun 30, 2023 |
-1,887.74% |
| Mar 31, 2023 |
-48.79% |
| Dec 31, 2022 |
-79.26% |
| Sep 30, 2022 |
-33.29% |
| Jun 30, 2022 |
-25.01% |
| Mar 31, 2022 |
-51.44% |
| Dec 31, 2021 |
-7.56% |
| Sep 30, 2021 |
-76.90% |
| Jun 30, 2021 |
25.75% |
| Mar 31, 2021 |
13.55% |
| Dec 31, 2020 |
139.08% |
| Sep 30, 2020 |
59.27% |
| Jun 30, 2020 |
128.30% |
| Mar 31, 2020 |
80.14% |
| Dec 31, 2019 |
-15,642.50% |
| Sep 30, 2019 |
-640.74% |
| Jun 30, 2019 |
-575.00% |
